(VIANEWS) – Eagle Pharmaceuticals (EGRX), Westamerica Bancorporation (WABC), StoneCastle Financial Corp (BANX) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Eagle Pharmaceuticals (EGRX)

45.1% sales growth and 10.53% return on equity

Eagle Pharmaceuticals, Inc. is a US-based pharmaceutical company. It specializes in developing and marketing product candidates for diseases of central nervous systems or metabolic critical care. Ryanodex is available for malignant heath; and Belrapzo and Bendeka are offered for chronic lymphocytic and non-Hodgkin’s lymphomas. EP-4104 is a dantrolene salt to treat organophosphates exposure. PEMFEXY is a ready to use/diluted liquid form of pemetrexed. EA-114 (fulvestrant), for HR+/HER- breast carcinoma. Vasopressin injection can be used to increase blood pressure in patients with vasodilatory stress. Combioxin, SA has a license agreement and collaboration agreement for the development of CAL02, an antibiotic agent to treat severe pneumonia. AOP Orphan Pharmaceuticals GmbH owns the rights for Landiolol, a new therapeutic product that can be used for the temporary reduction in ventricular rate for patients suffering from supraventricular tachycardia, atrial fibrillation, and atrial flutter. For the treatment of breast cancer (HR+/HER2-), and metastatic sarcomas at high risk, it has a partnership with Tyme Technologies, Inc. Eagle Pharmaceuticals, Inc., was established in 2007. It is located in Woodcliff Lake, New Jersey.

Earnings Per Share

As for profitability, Eagle Pharmaceuticals has a trailing twelve months EPS of $1.68.

PE Ratio

Eagle Pharmaceuticals has a trailing twelve months price to earnings ratio of 17.22. Meaning,
the purchaser of the share is investing $17.22 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.53%.

Sales Growth

Eagle Pharmaceuticals’s sales growth is 35.6% for the current quarter and 45.1% for the next.

Moving Average

Eagle Pharmaceuticals’s value is way below its 50-day moving average of $37.71 and way below its 200-day moving average of $45.03.

2. Westamerica Bancorporation (WABC)

22.7% sales growth and 12.57% return on equity

Westamerica Bancorporation is a holding bank for Westamerica Bank. It provides various banking services and products to individuals and businesses. It accepts deposits from all types, such as checking and retail savings accounts as well as certificates. The company’s loan portfolio includes residential, commercial, and residential real property, construction and consumer loans. It also offers loans that mainly consist of indirect automobile loans. Westamerica Bancorporation has 79 branches in 21 California counties. The former name of the company was Independent Bankshares Corporation. In 1983, it changed its name from Westamerica Bancorporation. Westamerica Bancorporation is located in San Rafael in California. It was established in 1972.

Earnings Per Share

As for profitability, Westamerica Bancorporation has a trailing twelve months EPS of $3.1.

PE Ratio

Westamerica Bancorporation has a trailing twelve months price to earnings ratio of 17.98. Meaning,
the purchaser of the share is investing $17.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.57%.

Sales Growth

Westamerica Bancorporation’s sales growth is 15.5% for the current quarter and 22.7% for the next.

Yearly Top and Bottom Value

Westamerica Bancorporation’s stock is valued at $55.77 at 11:22 EST, way under its 52-week high of $63.43 and above its 52-week low of $53.27.

Moving Average

Westamerica Bancorporation’s worth is under its 50-day moving average of $57.58 and under its 200-day moving average of $58.41.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Aug 4, 2022, the estimated forward annual dividend rate is 1.68 and the estimated forward annual dividend yield is 2.8%.

3. StoneCastle Financial Corp (BANX)

21.6% sales growth and 6.79% return on equity

StoneCastle Financial Corp., a closed-ended balanced mutual fund managed by StoneCastle Asset Management LLC is launched. The fund invests in the United States’ public equity markets. It invests in stock of banks and other financial companies. The fund invests in companies that pay dividends and growth stocks. The fixed income component of the fund is invested in subordinated bonds securities that are BBB- and better by Kroll Ratings. To create its portfolio, the fund uses fundamental analysis and bottom-up security selection. This includes reviewing historical and potential financial data, interviewing key bank employees, financial models, projections and financial models, as well as interviews with managers and other staff. To create its portfolio, it uses proprietary research. StoneCastle Financial Corp., which was established February 7, 2013, is based in the United States.

Earnings Per Share

As for profitability, StoneCastle Financial Corp has a trailing twelve months EPS of $1.18.

PE Ratio

StoneCastle Financial Corp has a trailing twelve months price to earnings ratio of 15.7. Meaning,
the purchaser of the share is investing $15.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.79%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 20, 2022, the estimated forward annual dividend rate is 1.56 and the estimated forward annual dividend yield is 8.6%.

Yearly Top and Bottom Value

StoneCastle Financial Corp’s stock is valued at $18.60 at 11:22 EST, way under its 52-week high of $24.19 and higher than its 52-week low of $17.32.

Volume

Today’s last reported volume for StoneCastle Financial Corp is 4891 which is 64.34% below its average volume of 13717.

4. CyberOptics Corporation (CYBE)

17.8% sales growth and 20.53% return on equity

CyberOptics Corporation develops and produces high-precision sensing technologies and products that are used in inspection and metrology around the world. Multi-reflection suppress (MRS), a technology that allows for multi-functional systems, such as the MX3000 MRS inspection system and 3D NanoResolution SRS sensor. The inspection and metrology system is used for advanced semiconductor wafer inspection and packaging inspection. SQ3000 multi-function systems, QX Series 2D AoI products and MX products to inspect memory modules. It also offers advanced packaging products and semiconductor wafers. The company also offers industrial metrology services such as CyberGage360, which can be used as an off-line and near-line tool for measuring distances, 3D scanning, metrology equipment and automatic calibration. The company sells products to SMT electronics assembly circuit board makers, end-users manufacturing their own circuit boards and semiconductor manufacturers. It also outsources semiconductor assembly and testing companies through independent distributors and sales reps. CyberOptics Corporation is located in Minneapolis, Minnesota.

Earnings Per Share

As for profitability, CyberOptics Corporation has a trailing twelve months EPS of $2.14.

PE Ratio

CyberOptics Corporation has a trailing twelve months price to earnings ratio of 24.98. Meaning,
the purchaser of the share is investing $24.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.53%.

Yearly Top and Bottom Value

CyberOptics Corporation’s stock is valued at $53.45 at 11:22 EST, below its 52-week high of $53.64 and way above its 52-week low of $30.98.

5. Lear Corporation (LEA)

11.6% sales growth and 4.09% return on equity

Lear Corporation develops and manufactures automotive seating and other electrical distribution systems for original equipment producers in North America and Europe. The company’s Seating segment includes leather and fabric products as well as seat covers, recliner mechanism, seat tracks, foams, structures and mechanisms and headrests. It also offers light trucks and compact cars. E-Systems is the company’s electrical distribution segment. It routes electrical signals and networks and manages electrical power in vehicles for different powertrains such as hybrid, plug-in hybrid and traditional internal combustion engines. These products include wire harnesses as well as terminals and connectors. They also offer electronic control modules such body control modules and smart junction boxes. Gateway modules and wireless transmitter technology are available. There is also lighting control modules and audio domain controllers. Amplifiers and modules for communication. The company also offers electrification products that consist of charging systems including onboard charging units and cord set charging devices; battery electronics which include battery disconnect units and cell monitoring supervisory system, integrated total batteries control modules; as well as other power management modules such converters and inverter modules. This segment also offers cybersecurity software, advanced vehicle positioning, which allows for autonomous and automated driving; roadside modules, which communicate real-time information to the traffic control system; and cellular protocols that allow vehicle connectivity. It was established in 1917. The headquarters are in Southfield in Michigan.

Earnings Per Share

As for profitability, Lear Corporation has a trailing twelve months EPS of $1.9.

PE Ratio

Lear Corporation has a trailing twelve months price to earnings ratio of 62.99. Meaning,
the purchaser of the share is investing $62.99 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.09%.

Moving Average

Lear Corporation’s value is way below its 50-day moving average of $140.85 and way below its 200-day moving average of $146.52.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Aug 30, 2022, the estimated forward annual dividend rate is 3.08 and the estimated forward annual dividend yield is 2.5%.

6. Cooper Companies (COO)

11.4% sales growth and 14.39% return on equity

Together with its subsidiaries, The Cooper Companies, Inc. develops, produces, and markets contact lenses. CooperVision is one segment, while CooperSurgical is the other. CooperVision offers both spherical lenses, which correct near- and farsightedness, as well as multifocal and toric lenses. These lenses can correct vision problems such as presbyopia and myopia in Americas, Europe and the Middle East as well as eye fatigues and ocular dryness. CooperSurgical is a segment that focuses on women and their health. It provides contraception, medical devices and genomics to healthcare professionals worldwide. The company offers office and surgical products including PARAGARD and uterine manipulators as well as retractors and closures, point-of-care products, LEEP products and endosee products. It also provides fertility products and services such as fertilization consumables, equipment and embryo options. It was established in 1958 by The Cooper Companies, Inc. and has its headquarters in San Ramon, California.

Earnings Per Share

As for profitability, Cooper Companies has a trailing twelve months EPS of $45.38.

PE Ratio

Cooper Companies has a trailing twelve months price to earnings ratio of 5.82. Meaning,
the purchaser of the share is investing $5.82 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.39%.

Moving Average

Cooper Companies’s worth is way under its 50-day moving average of $306.78 and way below its 200-day moving average of $357.08.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jul 25, 2022, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 0.02%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 5% and positive 4.9% for the next.

Volume

Today’s last reported volume for Cooper Companies is 285319 which is 3.65% below its average volume of 296150.

7. Archer (ADM)

6.3% sales growth and 15.68% return on equity

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, Cayman Islands, Brazil, Mexico, the United Kingdom, and internationally. It operates in three main segments, Ag Services and Oilseeds and Carbohydrate Solutions and Nutrition. The company procures, cleans and transports raw agricultural materials such as oil, oilseeds and corn. It also deals in agricultural commodities and feed products import, export and distribution. It also offers vegetable oils and protein meal ingredients; food, feed and energy products and raw vegetable oils. The company also offers peanuts and peanut-derived ingredients as well as cotton cellulose pulp, sweeteners and corn and wheat starches; syrup, glucose and wheat flour; alcohol and other feed ingredients; ethyl and ethanol; corn Gluten feed and meal; distillers grains and citric acid. The company also offers natural flavorings and flavors as well as proteins, natural colors and emulsifiers. It also provides soluble fiber, polyols and hydrocolloids and natural nutrition products. This includes probiotics and prebiotics and enzymes. The company offers commodity brokerage, futures commission merchant, commodity margin merchant and cash margins. Securities pledged to commodity clearinghouses can also be offered. It may also pledge cash as security for certain insurance agreements. Chicago is the headquarters of this company, which was established in 1902.

Earnings Per Share

As for profitability, Archer has a trailing twelve months EPS of $3.68.

PE Ratio

Archer has a trailing twelve months price to earnings ratio of 21.97. Meaning,
the purchaser of the share is investing $21.97 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.68%.

Yearly Top and Bottom Value

Archer’s stock is valued at $80.86 at 11:22 EST, way below its 52-week high of $98.88 and way above its 52-week low of $60.83.

Volume

Today’s last reported volume for Archer is 1272510 which is 51.94% below its average volume of 2648180.

LEAVE A REPLY

Please enter your comment!
Please enter your name here